In a major executive reshuffle for 2025, Lotte Group replaced 36% of its affiliate CEOs and reduced the overall number of executives by 13%. This change is the largest in scale so far, especially targeting the chemical sector, where 10 out of 13 CEOs were replaced. Meanwhile, Yoon Lee, the CEO of Lotte Chemical Advanced Materials, has been appointed as the new head of the chemical division.
Shin Yoo-yeol, the son of Chairman Shin Dong-bin and part of the third generation of the Lotte family, was promoted to Vice President, stepping into a more prominent management role. Lotte held board meetings for 37 affiliates, including Lotte Holdings, and replaced 21 CEOs, focusing on fundamentally changing its management structure and ensuring accountability for performance.
In the chemical division, three representatives selectively remained while companies like Lotte Aluminum, Lotte Energy Materials, and LC USA retained their CEOs. Yoon Lee advanced from Vice President to President at Lotte Chemical.
In Hotel Lotte, all heads from its subsidiaries, including Lotte Hotels, Lotte Duty Free, and Lotte World, were replaced. Hoh-seok Jung, Vice President of Business Support at Lotte Holdings, has been appointed as the new CEO of Hotel Lotte. Lotte Duty Free appointed Director Dong-ha Kim, who was promoted to Executive Vice President, as the new CEO, while for Lotte World, O-sang Kwon, Executive Vice President and Head of New Business Department, was named the new CEO.
At Lotte Holdings, Jin-hyung Roh, the Vice President of Management Innovation, was promoted to President. Additionally, the Management Innovation Office and Business Support Office at Lotte Holdings were consolidated to play a central role in restructuring and innovating business operations across the Group.
Vice President Yoo-yeol Shin, who heads the Future Growth Department at Lotte Holdings, will also oversee the Global Strategy Department at Lotte Biologics. He is expected to actively lead new and global businesses, focusing on successfully establishing new ventures such as Bio CDMO and expanding core business markets globally.